AbCellera Biologics Aktie

Kaufen

Verkaufen

Aktien-Sparplan anlegen Aktien-Sparplan anlegen

5,00 EUR -0,01 EUR -0,12 %

06.10.2025

BMN

5,89 USD +0,03 USD +0,43 %

nachbörslich06.10.2025

BTT

AbCellera Biologics jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)

Jetzt loslegen

Direkt handeln

Bei einem anderen Broker handeln

Marktkap.1,51 Mrd. EUR

Div. Rendite0,00%

WKNA2QKXS

ISINCA00288U1066

SymbolABCL

AbCellera Biologics Aktien News

Sortieren:Datum Meistgelesen

17.04.23BusinesswireAbCellera Presents New Data on T-Cell Engager Platform at AACR 2023

11.04.23BusinesswireAbCellera to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference on April 25, 2023

06.04.23BusinesswireAbCellera to Report First Quarter 2023 Financial Results on May 4, 2023

22.03.23BusinesswireAbCellera and RQ Bio Partner to Accelerate the Advancement of New Therapies for Infectious Disease

14.03.23BusinesswireAbCellera Announces Two Presentations on T-Cell Engager Discovery at AACR 2023

23.02.23BusinesswireAbCellera to Present at the Cowen 43rd Annual Health Care Conference on March 6, 2023

21.02.23BusinesswireAbCellera Reports Full Year 2022 Business Results

01.02.23BusinesswireAbCellera to Present at the SVB Securities Global Biopharma Conference on February 15, 2023

24.01.23BusinesswireAbCellera to Report Full Year 2022 Financial Results on February 21, 2023

20.01.23BusinesswireAbCellera Announces that the U.S. Patent Trial and Appeal Board Upholds Microfluidic Cell Culture Patent

04.01.23BusinesswireAbCellera to Present at the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023

15.12.22BusinesswireAbCellera and AbbVie Partner to Advance New Antibody Therapies

01.12.22BusinesswireAbCellera and Rallybio Announce Strategic Alliance to Discover, Develop, and Commercialize Novel Antibody-Based Therapeutics for Rare Diseases

10.11.22BusinesswireAbCellera Presents New Data on Further Development and Characterization of T-Cell Engager Platform at SITC 2022

08.11.22BusinesswireAbCellera Reports Q3 2022 Business Results

04.11.22BusinesswireAbCellera to Present at Upcoming Investor Conferences in November

02.11.22BusinesswireAbCellera’s First Program with Regeneron in Multi-Target Collaboration Advances in Preclinical Development

11.10.22BusinesswireAbCellera to Report Third Quarter 2022 Financial Results on November 8, 2022

AbCellera Biologics News

AbCellera Biologics News: auf dieser Seite finden Sie alle AbCellera Biologics News und Nachrichten zur AbCellera Biologics Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch AbCellera Biologics News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um AbCellera Biologics News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.